EP 1638604 A2 20060329 - PASSIVE IMMUNE THERAPY AGAINST MALIGNANT MELANOMA
Title (en)
PASSIVE IMMUNE THERAPY AGAINST MALIGNANT MELANOMA
Title (de)
PASSIVE IMMUNTHERAPIE GEGEN MALIGNES MELANOM
Title (fr)
IMMUNOTHERAPIE PASSIVE CONTRE LE MELANOME MALIN
Publication
Application
Priority
- EP 2004006519 W 20040617
- DE 10328121 A 20030623
Abstract (en)
[origin: WO2005000349A2] Disclosed is the use of antibodies for producing an immunizing vaccine against HMW-MAA on melanomas.
IPC 1-7
IPC 8 full level
C07K 16/30 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07K 16/3053 (2013.01); A61K 2039/505 (2013.01); C07K 2317/73 (2013.01)
Citation (search report)
See references of WO 2005000349A2
Citation (examination)
- WO 8911296 A1 19891130 - FERRONE SOLDANO [US], et al
- WILSON B S ET AL: "Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 15 SEP 1981 LNKD- PUBMED:7033148, vol. 28, no. 3, 15 September 1981 (1981-09-15), pages 293 - 300, ISSN: 0020-7136
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005000349 A2 20050106; WO 2005000349 A3 20050506; AU 2004251010 A1 20050106; CA 2530655 A1 20050106; DE 10328121 A1 20050203; EP 1638604 A2 20060329; IL 172751 A0 20060410
DOCDB simple family (application)
EP 2004006519 W 20040617; AU 2004251010 A 20040617; CA 2530655 A 20040617; DE 10328121 A 20030623; EP 04763003 A 20040617; IL 17275105 A 20051222